MARILU ARVIZU: Open Payments
NPI 1699467506 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$609 in 7 payments from 5 companies in 2025. Trend: 2023 $238 · 2024 $708 · 2025 $609
Food & beverage: $510Education: $99
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $230 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $122 |
| Janssen Biotech, Inc. | 2 | $112 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: JEMPERLI, DATROWAY, ZEJULA, ERLEADA, KISQALI, TECVAYLI.
Industry payments across WI — which companies pay providers there.
